Quinidine.
Grace
A A
AA
Department of Medicine, University of Cambridge, Papworth Hospital, United Kingdom.
Camm
A J
AJ
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001281:Atrial Fibrillation / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004077:Digoxin / Q000494:pharmacology / Q000627:therapeutic use; D004347:Drug Interactions; D004594:Electrophysiology; D006321:Heart / Q000187:drug effects*; D006801:Humans; D015221:Potassium Channels / Q000187:drug effects*; D011802:Quinidine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D015222:Sodium Channels / Q000187:drug effects*
D000889:Anti-Arrhythmia Agents; D015221:Potassium Channels; D015222:Sodium Channels; D004077:Digoxin; D011802:Quinidine